MedPath

In Vitro Follicle Activation

Not Applicable
Terminated
Conditions
Infertility
Primary Ovarian Insufficiency
Interventions
Procedure: In Vitro Follicle Activation (IVA)
Drug: Follicle Activation
Registration Number
NCT02496598
Lead Sponsor
National Foundation for Fertility Research
Brief Summary

The purpose of this study is to evaluate the effectiveness of an experimental treatment, known as in vitro activation (IVA) of dormant ovarian follicles, for infertility in women diagnosed with primary ovarian insufficiency (POI).

Detailed Description

The purpose of this study is to evaluate the effectiveness of an experimental treatment, known as in vitro activation (IVA) of dormant ovarian follicles, for infertility in women diagnosed with primary ovarian insufficiency (POI; also known as premature ovarian failure). Patients diagnosed with POI are infertile due to a lack of follicle growth and ovulation; oocyte donation is the only treatment option currently available to enable these women to have a child. IVA treatment may result in the rescue of the remaining primordial follicles within the ovary, thus making oocytes available for IVF, embryo production, transfer and pregnancy. In this experimental treatment, ovarian tissue is removed from the patient and cultured in vitro for 48 hours with specific compounds to activate dormant primordial follicles. Following activation ovarian tissue is auto-grafted to the serosa of the fallopian tube, and the patient is monitored for signs of follicle growth. Growing follicles are stimulated with exogenous hormones, followed by oocyte retrieval and IVF.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
2
Inclusion Criteria
  • Women diagnosed with primary ovarian insufficiency (POI), seeking pregnancy and eligible for IVF at Colorado Center for Reproductive Medicine (Lone Tree, CO).
  • Patients can be of any race, culture, sexual orientation or ethnicity.
Exclusion Criteria
  • Minors are excluded from participation in this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
In Vitro Follicle Activation (IVA)In Vitro Follicle Activation (IVA)Ovarian tissue will be removed and cultured in vitro with compounds to activate dormant follicles. Following activation, ovarian tissue will be auto-grafted and the patient monitored for follicular growth.
In Vitro Follicle Activation (IVA)Follicle ActivationOvarian tissue will be removed and cultured in vitro with compounds to activate dormant follicles. Following activation, ovarian tissue will be auto-grafted and the patient monitored for follicular growth.
Primary Outcome Measures
NameTimeMethod
Recovery of oocytes by trans-vaginal ultrasound guided oocyte aspiration1 year after auto-grafting

The number of oocytes recovered from follicles developing in the grafted ovarian tissue following in vitro activation

Pregnancy1.5 years after auto-grafting

The incidence of implantation and pregnancy following transfer of embryos produced from oocytes recovered from follicles developing in the activated ovarian tissue.

Antral follicle development measured by ultrasound examination1 year after auto-grafting

Ultrasound analysis of the number of follicles developing in the grafted ovarian tissue following activation in vitro

Secondary Outcome Measures
NameTimeMethod
Offspring gender1 year after egg retrieval

The gender of children born

Development of good quality blastocysts using the Gardner morphological blastocyst grading system1 week after egg retrieval

The proportion of good quality blastocyst stage embryos developed during in vitro fertilization (IVF) cycle(s), of the total number of fertilized eggs

Offspring weight1 year after egg retrieval

The birth weight of children born

Trial Locations

Locations (2)

National Foundation for Fertility Research

🇺🇸

Lone Tree, Colorado, United States

Fertility Laboratories of Colorado

🇺🇸

Lone Tree, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath